Shilpa Medicare jumped 6.40% to Rs 741.90 after the company informed that it has successfully completed phase-3 clinical studies of its product SMLNUD07 – Nor Ursodeoxycholic Acid (NorUDCA) tablets.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
